LEUKEMIA, MYELOID, CHRONIC-PHASE
Clinical trials for LEUKEMIA, MYELOID, CHRONIC-PHASE explained in plain language.
Never miss a new study
Get alerted when new LEUKEMIA, MYELOID, CHRONIC-PHASE trials appear
Sign up with your email to follow new studies for LEUKEMIA, MYELOID, CHRONIC-PHASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Diabetes drug could help eradicate hidden leukemia cells
Disease control CompletedThis phase 2 trial tests whether adding pioglitazone (a diabetes drug) to the standard leukemia medication imatinib can eliminate remaining cancer cells in people with chronic-phase chronic myeloid leukemia (CML). Participants must have been on imatinib for at least two years and…
Matched conditions: LEUKEMIA, MYELOID, CHRONIC-PHASE
Phase: PHASE2 • Sponsor: Versailles Hospital • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Real-World CML treatment patterns revealed in large U.S. study
Knowledge-focused CompletedThis study looked back at medical records of 1,480 people with chronic-phase chronic myeloid leukemia (CML) treated in U.S. community oncology clinics between 2016 and 2022. Researchers examined which drugs were used, how doses were adjusted, and how well patients responded. The …
Matched conditions: LEUKEMIA, MYELOID, CHRONIC-PHASE
Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC